TerrAscend (TSNDF) Operating Expenses (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Operating Expenses of $23.1 million for Q1 2026, up 2.87% year-over-year from $22.4 million in Q1 2025, and down 13.93% quarter-over-quarter from $26.8 million in Q4 2025.
TerrAscend (TSNDF) Operating Expenses (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Operating Expenses for 6 consecutive years, with $23.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 2.87% year-over-year to $23.1 million; the TTM figure through Mar 2026 stood at $94.9 million (changed 0.39% YoY), while the FY2025 annual figure was $94.3 million, down 2.73% from the prior year.
- Operating Expenses fell to $23.1 million in Q1 2026 per TSNDF's latest filing, from $26.8 million in the prior quarter.
- Across five years, Operating Expenses topped out at $361.2 million in Q3 2022 and bottomed at $15.4 million in Q4 2023.
- Historically, Operating Expenses has averaged $45.2 million across 5 years, with a median of $23.6 million in 2022.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 1452.61% — and 2023, when it slumped 91.67%.
- TerrAscend's Operating Expenses stood at $17.1 million in 2022, then retreated by 9.92% to $15.4 million in 2023, then jumped by 52.57% to $23.5 million in 2024, then gained by 14.32% to $26.8 million in 2025, then fell by 13.93% to $23.1 million in 2026.
- Business Quant data shows TSNDF's Operating Expenses at $23.1 million in Q1 2026, $26.8 million in Q4 2025, and $22.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | 24.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.14 Mn |
| Mar 31, 2026 | 23.08 Mn |
| Dec 31, 2025 | 26.82 Mn |
| Sep 30, 2025 | 22.78 Mn |
| Jun 30, 2025 | 22.26 Mn |
| Mar 31, 2025 | 22.44 Mn |
| Dec 31, 2024 | 23.46 Mn |
| Sep 30, 2024 | 25.96 Mn |
| Jun 30, 2024 | 22.72 Mn |
| Mar 31, 2024 | 32.66 Mn |
| Dec 31, 2023 | 15.38 Mn |
| Sep 30, 2023 | 30.08 Mn |
| Jun 30, 2023 | 32.73 Mn |
| Mar 31, 2023 | 30.09 Mn |
| Dec 31, 2022 | 17.07 Mn |
| Sep 30, 2022 | 361.25 Mn |
| Jun 30, 2022 | 35.51 Mn |
| Mar 31, 2022 | 23.60 Mn |
| Dec 31, 2021 | 12.83 Mn |
| Sep 30, 2021 | 23.27 Mn |